Platelets, coagulation and fibrinolysis in breast cancer progression
about
Tumor-Associated Macrophages and Neutrophils in Tumor MicroenvironmentBreast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerThe integrative epigenomic-transcriptomic landscape of ER positive breast cancer.Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasisFunctional impairment of activated protein C in breast cancer - relationship to survival outcomes.Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release.Cancer and Thrombosis: The Platelet Perspective.Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical TreatmentPrognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer.From plasminogen to plasmin: role of plasminogen receptors in human cancer.Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditionsProteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and PerspectivesNam Dia long, a Vietnamese folk formula, induces apoptosis in MCF-7 cells through various mechanisms of action.Understanding and treating solid tumor-related disseminated intravascular coagulation in the "era" of targeted cancer therapies.Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.Oxidant stress as a major determinant of platelet activation in invasive breast cancer.Platelet phenotype changes associated with breast cancer and its treatment.Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients.Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach.Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.An isoform of AIF1 involved in breast cancer
P2860
Q26766429-A70C31F1-1DF7-445B-A83E-9FC0DC31DE5FQ34657739-9D63C999-7A34-4B5D-A214-BCAEE3DCE8C1Q36286724-CF27D4F5-08E5-4388-A014-9434C2D4226AQ36357800-81E2853F-ADF1-4505-A6B8-D5913455DE40Q36546059-7DCC0803-FD92-488D-9E0D-2D7AF5682891Q36843779-9D84FB34-6334-4607-95CB-DA1DDD8EEB95Q37077438-F32776A6-D822-4C0C-99E4-89B2175F0AA8Q37330296-D687F2D8-3A2A-4817-B3A5-DDEF4E9A92DEQ37386201-2E134EBC-66A0-43F1-B4AA-44725061C17BQ37558436-A21B3F30-243D-40CD-92AB-9B38E1D34F6FQ37624146-07D5EA8A-EEB5-4DBC-9406-5940AC158EB0Q37706180-3C891C77-B9D5-4827-9C3F-308A2418E5B6Q38174455-F29E2E30-056E-4FD5-A444-6C418E92BEB6Q38269342-ECE36199-4D8F-4E4E-B91D-D2B5F9340395Q38741821-26370E2D-8422-4D6F-9C04-2F39F73817F7Q38823622-95732366-D8C9-4821-A6B9-DA98E99A8BD4Q38937289-EC0BE09D-8917-4492-8F22-F2CE3225C6B2Q40546472-0A4BD103-5126-4C76-A27E-C9F69398A567Q41585931-543C2AEB-817B-49AC-A02E-FF0912EA38E3Q47135280-0D352F7F-6698-4660-A448-EA66F7870E1EQ47274345-E6732AE4-0925-4E0A-95EE-D052394CDBE7Q50897118-13AB843D-BC0B-4910-90DD-6B42C6B0EE79Q51361563-E8794B83-7E2C-4966-82DB-1962C051D240Q52838770-97A5FE8C-B8CF-420B-931E-E323F0FE6BE8Q54939232-4EB8E10B-3AF9-4435-A8AC-98B9888CF350Q54941802-9AD36895-2A49-4EBB-9976-D6C490231225Q55236680-AB61A174-A9DC-4A70-B1D0-2362E66E3D94Q58579151-9DB5DAEC-E86A-4BA2-B390-126F7F66DC80
P2860
Platelets, coagulation and fibrinolysis in breast cancer progression
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Platelets, coagulation and fibrinolysis in breast cancer progression
@ast
Platelets, coagulation and fibrinolysis in breast cancer progression
@en
Platelets, coagulation and fibrinolysis in breast cancer progression
@nl
type
label
Platelets, coagulation and fibrinolysis in breast cancer progression
@ast
Platelets, coagulation and fibrinolysis in breast cancer progression
@en
Platelets, coagulation and fibrinolysis in breast cancer progression
@nl
prefLabel
Platelets, coagulation and fibrinolysis in breast cancer progression
@ast
Platelets, coagulation and fibrinolysis in breast cancer progression
@en
Platelets, coagulation and fibrinolysis in breast cancer progression
@nl
P2093
P2860
P921
P3181
P356
P1476
Platelets, coagulation and fibrinolysis in breast cancer progression
@en
P2093
Chris E Holmes
Kim Dittus
P2860
P2888
P3181
P356
10.1186/BCR3425
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1009488058